WHO ICTRP trial

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study…

EUCTR2011-004590-90-DE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2011-004590-90-DE
Public title A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to Clostridium difficile toxin B), and MK-3415A (Human Monoclonal Antibodies to Clostridium difficile toxin A and toxin B) in Patients Receiving Antibiotic Therapy for Clostridium difficile Infection
Scientific title A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium difficile toxin A), MK-6072 (Human Monoclonal Antibody to Clostridium difficile toxin B), and MK-3415A…
Primary sponsor Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Portugal;United States;Spain;Austria;Israel;Chile;Colombia;Italy;United Kingdom;India;Czech Republic;Mexico;Puerto Rico;Canada;Belgium;Brazil;Denmark;Australia;South Africa;Germany;New Zealand
Conditions recurrence of Clostridium difficile infection (CDI) MedDRA version: 14.1 Level: PT Classification code 10054236 Term: Clostridium difficile infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C]…
Interventions Product Code: MK-3415 Pharmaceutical Form: Solution for injection INN or Proposed INN: NA CAS Number: NA Current Sponsor code: MK-3415 Other descriptive name: MK-3415 Concentration unit: mg/kg milligram(s)/kilogram Concentration type: equal…
Registration date Nov 22, 2011
Target size 1600
Secondary IDs 3415A-001
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations